speb/financial-data huggingface dataset:
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: -582600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 24348400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 24182500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -174780000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 10700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 35562200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 24781300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 5019600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 24348400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 5442500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 11213800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 15302600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1047800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 4600000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -582600000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -582600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 10093600000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2705400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 5211700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 70402238.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 37.54
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2371000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 312500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 312500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 70533760.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 37.47
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — EBIT: 3008500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — EBITDA: 3321000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 2840700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 74200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 74200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Income: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2642900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -74200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -74200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 565800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 161313904.51
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Operating Income: 135300000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 5211700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 118000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1400200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: -2755200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 2934300000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2371000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 312500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 2755200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 273613904.51
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 291400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.10
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 5076400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 2755200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 2755200000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — +Operating Expense: 9392400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2900300000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — +Total Revenue: 21594100000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 5751200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3566300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3566300000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 8285800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 8285800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -7520700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -7520700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 137900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 137900000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -53300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -53300000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Amortization: 65800000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 65800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 86100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 86100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 70405750.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 70387097.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Basic EPS: 35.91
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.55
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 895800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 5627300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 5627300000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1230400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 313700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 313700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 2894800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2894800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2894800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2894800000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -3700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 2206800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 2206800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 688000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 688000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 137700000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Change In Payable: -2010200000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -208800000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2081300000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 1975600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 27174400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 27174400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1153100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1153100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 11566000000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2680200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Current Assets: 21973400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 21973400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 53700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 53700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt: 4296600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 4296600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 4350300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4350300000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 8859400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 8859400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 47000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 47000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Depreciation: 1185400000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1251200000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1251200000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 306100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 1185400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 306100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 70532904.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 70387097.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Diluted EPS: 35.85
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.55
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 109100000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 5800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 5800000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — EBIT: 3238600000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — EBIT: 281800000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — EBITDA: 4489800000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — EBITDA: 587900000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — End Cash Position: 2894800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 18600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 4610800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4610800000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -1194000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -23400000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -19900000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -2742900000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 573200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 88800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 88800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 8339100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 8339100000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 20710800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 20710800000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Gross Profit: 10028100000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3071000000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Interest Expense: 314800000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 93900000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 314800000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 93900000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Interest Income: 53000000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 53000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -249300000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 56000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Inventory: 9749700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 9749700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 31862200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 31862200000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 1920600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 0.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 485600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 485600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Liabilities Heldfor Sale Non Current: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Liabilities Heldfor Sale Non Current: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 260000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 260000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 391200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 391200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 651200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 651200000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -418800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 286400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 286400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 13444800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 13444800000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 40000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1793000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1793000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -58800000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Income: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Income: 109100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 109100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 109100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 109100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 109100000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2923800000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 2528400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 109100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: -262900000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -93900000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 0.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 334500000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -418800000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -262900000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -93900000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 228600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 13190100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 13190100000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 1596000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 753300000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 27085600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 27085600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 4200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 4200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 305600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 305600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 398800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 398800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 286400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 286400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 1782700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 1782700000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2412000000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 711500000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 731591216.91
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 183260000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 36400000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Operating Income: 635700000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 170700000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 21594100000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 5751200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 23400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 946100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 946100000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 299200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 299200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 59300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 59300000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 73300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 73300000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 253600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 253600000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 844000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1848500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1848500000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 4200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 4200000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 7900000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 234700000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2244300000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1665700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Payable: 860400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 860400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Properties: 12037000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 12037000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 120700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 120700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 96400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 96400000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Other Special Charges: -1982300000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: 123600000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Payables: 4432500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Payables: 4432500000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 870200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 870200000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Pretax Income: 2923800000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 187900000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -11100000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1230400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 3549700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 3549700000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 11566000000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2680200000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1251200000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 306100000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 24300000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 24300000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -418800000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 52200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 52200000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 27076400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 27076400000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 40000000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 2826400000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 1752400000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 2325600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Share Issued: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 70405750.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Special Income Charges: 1982300000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -123600000.00
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 8100000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 27174400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 27174400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 27085600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 27085600000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 280991216.91
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -49440000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Tax Provision: 395400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 78800000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.14
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
UNICHEMLAB.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -75700000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Assets: 37374400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 37374400000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 27565600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 27565600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Debt: 5001500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 5001500000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 27174400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 27174400000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Total Expenses: 20958400000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 5580500000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 10200000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 10200000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 15401000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 15401000000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1340600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1340600000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 1100000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 2077800000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -123600000.00
UNICHEMLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 2077800000.00
UNICHEMLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -123600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Work In Process: 1335600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 1335600000.00
UNICHEMLAB.NS balance_sheet (annual, 2026-03-31) — Working Capital: 13114000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 13114000000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -173801000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 123470000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 20303126.00
UNIDT.NS income_statement (annual, 2022-03-31) — Basic EPS: 24.64
UNIDT.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 80967000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 11983000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 1461000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 20303126.00
UNIDT.NS income_statement (annual, 2022-03-31) — Diluted EPS: 24.64
UNIDT.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 10069000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 20533000.00
UNIDT.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 38502000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Interest Income: 9617000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 9617000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 6692000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 95693000.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 0.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 9618000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 0.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 7829000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 164600000.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -123223000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Other Payable: 31644000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 113708000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Other Special Charges: -193000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4628000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 0.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 113708000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: 0.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 225390000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 5050000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 5050000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 10069000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1841182000.00
UNIDT.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
UNIDT.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 14312000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 52814000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 137701000.00
UNIDT.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 5633000.00
UNIDT.NS balance_sheet (annual, 2022-03-31) — Work In Process: 904805000.00
UNIDT.NS income_statement (annual, 2023-03-31) — +Operating Expense: 226200000.00
UNIDT.NS income_statement (annual, 2023-03-31) — +Total Revenue: 1181253000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 136667000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 340689000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -375903000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 123470000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 37520000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 20303126.00
UNIDT.NS income_statement (annual, 2023-03-31) — Basic EPS: 5.03
UNIDT.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 22052000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 313385000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1531000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 203031000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 10768000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 10768000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -36546000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 10768000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -209807000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 147829000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -7435000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Change In Payable: 64081000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 118425000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 114404000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 186101000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Common Stock: 203031000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2470519000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
UNIDT.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 804678000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1935654000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Current Debt: 49719000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 49719000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 253000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 285793000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 94296000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Depreciation: 41330000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 41330000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 41330000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 41330000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 20303126.00
UNIDT.NS income_statement (annual, 2023-03-31) — Diluted EPS: 5.03
UNIDT.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 102746000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 11326000.00
UNIDT.NS income_statement (annual, 2023-03-31) — EBIT: 151797000.00
UNIDT.NS income_statement (annual, 2023-03-31) — EBITDA: 193127000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — End Cash Position: 22094000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -163978000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 11635000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 255519000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 99000.00
UNIDT.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 38147000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 279901000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 375903000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Gross Profit: 376575000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Interest Expense: 3716000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 3716000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Interest Income: 1972000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 1972000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Inventory: 1360535000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 2520601000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 93029000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 37520000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 38169000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 363000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 363000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -129404000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 10113000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 128260000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Net Debt: 39314000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Income: 102746000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 102746000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 102746000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 102746000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 102746000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 148081000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 102746000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Interest Income: -6294000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -129404000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -129404000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -6294000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 1972000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Net PPE: 375903000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 93030000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -129025000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2190618000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 45147000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 10113000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 164839000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 193028000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Normalized Income: 102677308.85
UNIDT.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 257050000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Operating Income: 150375000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Operating Revenue: 1181253000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 20303126.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -186059000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: -1000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 29049000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 384000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 279901000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 2483000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 22537000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 4419000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 3902000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 12077000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Payable: 53818000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Properties: 375903000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 37503000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Other Special Charges: -99000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Payables: 201811000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4862000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Preferred Securities Outside Stock Equity: 0.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 37503000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Pretax Income: 148081000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1531000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 183162000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 804678000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 41330000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 14117000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 14117000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -129404000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 11326000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1917103000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 94561000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 16296000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 54443000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Share Issued: 20303126.00
UNIDT.NS income_statement (annual, 2023-03-31) — Special Income Charges: 99000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2470519000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2190618000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 30308.85
UNIDT.NS income_statement (annual, 2023-03-31) — Tax Provision: 45335000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.31
UNIDT.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 174833000.00
UNIDT.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -45405000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Assets: 2816354000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 2470882000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Debt: 50082000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2470519000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Total Expenses: 1030878000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 345835000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 880700000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 60042000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 4550000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 99000.00
UNIDT.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 99000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Work In Process: 1165738000.00
UNIDT.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1649861000.00
UNIDT.NS income_statement (annual, 2024-03-31) — +Operating Expense: 356714000.00
UNIDT.NS income_statement (annual, 2024-03-31) — +Total Revenue: 1299668000.00
UNIDT.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 574450000.00